pharma companies working glp 1 Feds, Strike Deal for Low Cost GLP-1 Medications New oral GLP-1 drugs could

and the content it produces is for informational purposes only

Emerging evidence suggests the potential benefits of GLP-1 RAs in the treatment of IBD through enhanced mucosal healing and reduced inflammation

When used as a medication, GLP-1 receptor agonists do more than just control hungerthey also influence fat storage and metabolism at a cellular level

The figure below captures this central tension: payers are almost evenly split in their perspectives on treatment of obesity, with some regarding pharmaceutical coverage for obesity as a response to a chronic medical condition, while others see it more as addressing a lifestyle issue